120MO Inupadenant Combined with Chemotherapy in Patients with Non-Squamous NSCLC Progressing on or after Immune Checkpoint Inhibitor Therapy: Results from Dose-Finding Part of the A2A-005 Trial

K. Cuppens, G. Lo Russo,O.J. Juan Vidal, E. Felip, M.C. Areses Manrique, A. Chiappori, E. Govaerts,P.K. Cheema,L. Greillier, L. Toschi, E. Schaefer, M. Clouseau, C. Martinoli, H. Shehade, N. Byrne, M. Fox, M. Rossetti, O. De Henau, S. Ross,S. Peters

Immuno-Oncology and Technology（2024）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined